Table 2.
Comorbidity incidence in patients at the time of insulin initiation (n = 224)
| Comorbidity | n (%) of patients with comorbidity |
|---|---|
| Macrovascular complications (at least 1) | 86 (38.4) |
| Coronary disease | 49 (21.9) |
| Stroke | 18 (8.0) |
| Transient ischemic attack | 10 (4.5) |
| Peripheral occlusive arterial disease | 13 (5.8) |
| Congestive heart failure | 24 (10.7) |
| Amputation | 2 (0.9) |
| Microvascular complications (at least 1) | 36 (16.1) |
| Diabetic retinopathy | 15 (6.7) |
| Diabetic nephropathy | 23 (10.3) |
| Diabetic neuropathy | 9 (4.0) |
| Other comorbidities (at least 1) | 182 (81.3) |
| Hypertension | 137 (61.2) |
| Hyperlipidemia | 111 (49.6) |
| Depression | 29 (12.9) |
| Cancer | 12 (5.4) |
| Others | 48 (21.4) |